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Objective: This study examined whether extraction of particulate emboli using
intra-aortic filtration could decrease neurologic outcomes.
Methods: Patients (N  582) were enrolled in a prospective, controlled study and
alternately assigned to the therapy arm (n  304; intra-aortic filtration) or control
arm (n  278). Preoperative, procedural, and postoperative data were collected.
Neurologic examinations included the National Institutes of Health Stroke Scale,
Glasgow Coma Scale, and memory tests. Investigators administering neurologic
tests were blinded to the study arm. By the use of logistic regression and propensity
matching, composite neurologic outcomes (transient ischemic attack, stroke, delir-
ium, coma, and memory deficit) were evaluated.
Results: Patients in the filter group experienced a lower incidence of adverse
neurologic outcomes than patients in the control group (4.3% vs 11.9%) (P .001).
There were significantly less transient ischemic attacks (0% vs 1.4%), delirium
(3.0% vs 6.5%), and memory deficit (1.3% vs 6.2%). There were fewer strokes in
the filter group compared with the control group (0.7% vs 2.2%), although the
sample size was too small for a significant finding. Both groups experienced 1 coma
outcome. The use of a filter was associated with an adjusted odds ratio of 0.375,
implying that a patient who does not receive a filter is 2.7 times more likely to
experience an adverse neurologic event. Logistic modeling also demonstrated that
there are increasing chances of poor neurologic outcome with increasing age. The
model indicates that there may be an increasing protective benefit from the filter
with increasing age, although the interaction was not significant.
Conclusions: The extraction of particulate emboli using intra-aortic filtration re-
sulted in decreased neurologic outcomes.
Intra-aortic filtration entered the cardiac surgeon’s armamentarium in 1999.At present, it remains the only available method of capturing and extractingparticulate emboli from the circulation. Since its introduction, numerousstudies have been published highlighting risks to the patient undergoingcardiac surgery posed by particulate emboli and drawing links betweenaortic atherosclerosis, liberation of particulate debris during surgery, and
injury to distal organs.1-5
Several studies have examined intra-aortic filtration and described its effects. In
2000, Reichenspurner and colleagues6 reported that the extraction of particulate
emboli in patients undergoing cardiac surgery was feasible using intra-aortic filtra-
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tion. In a series of 77 patients, this article highlighted the
capture and removal of fibrous atheroma and other partic-
ulate debris. A larger study by Harringer and the Interna-
tional Council of Emboli Management (ICEM)7 showed
that the filter extracted particulate material from 240 of 243
patients, and that 62% of the filters contained fibrous ath-
eroma, which is of particular interest because the body does
not lyse fibrous atheroma.
Whereas 2 studies established the filter’s ability to cap-
ture and remove emboli, more recent studies examined the
clinical relevance of emboli capture and removal. By using
a published and validated stroke risk index, Schmitz and
Blackstone8 found that patients undergoing coronary artery
bypass graft (CABG) receiving intra-aortic filtration expe-
rienced approximately half the expected number of severe
neurologic outcomes. In high-risk patients undergoing com-
bined CABG and intracardiac procedures, even greater ben-
efit was found.9 In these patients, Wimmer-Greinecker9
reported 74% fewer type I outcomes (stroke, transient isch-
emic attack [TIA], coma, and death as the result of neuro-
logic causes) when compared with a previous study.10 The
current investigation used a prospective, controlled study
design to isolate the effect of the filter and examine whether
the extraction of particulate emboli can reduce neurologic
outcomes during cardiac surgery.
Methods
Eligible patients included all patients scheduled for CABG, valve,
or combined CABG and valve procedures in our center between
March 1999 and May 2002. Patients were excluded from the study
if they presented with carotid stenosis greater than 70% or left
ventricular ejection fraction less than 20% or if they received
off-pump surgery. Because some of the neurologic assessments
included verbal tests, patients who did not speak German as their
mother tongue were also excluded. The study was approved by the
local ethics committee and institutionally sanctioned; patient con-
sent was obtained.
Preoperatively, patients were nonrandomly assigned to either
the filter or control arm of the study at alternating intervals. Some
flexibility in the time periods was used to keep enrollment numbers
in both groups similar. Patients in both study arms received stan-
dard surgery per the normal protocols and procedures of our
center. These procedures included cardiopulmonary bypass using
aortic and 2-stage venous cannulas, a target flow rate of 2.4 L/m2
· min, and a core body temperature of 32°C to 34°C. Myocardial
protection was achieved using Buckberg’s cold blood cardioplegia
or Bretschneider’s cardioplegia. Central anastomoses were sewn
using a partial clamp after removal of the aortic crossclamp.
Patients in the filter arm received intra-aortic filtration in addi-
tion to their standard procedures. The intra-aortic filtration device
consisted of a 120-micron heparin-coated polyester mesh placed in
the aorta through a side port in the aortic cannula (EMBOL-X
System, Edwards Lifesciences, Irvine, Calif). Filter placement
occurred immediately before crossclamp release, and the device
remained indwelling until the patient was weaned off bypass. Full
details of the methods of filter usage have been previously de-
scribed.6-8 Filters were collected and sent to a central laboratory
for analysis (Stanford University, Palo Alto, Calif).7 Final enroll-
ment included 304 patients in the filter group and 278 patients in
the control group.
Neurologic assessment was performed on all patients at several
points: preoperatively, 48 hours postoperatively, and at discharge
(typically on the seventh postoperative day). Examinations in-
cluded the National Institutes of Health Stroke Scale, Glasgow
Coma Scale, and memory deficit questions. Neurologic examiners
received identical training in the Neurology Department of Bonn
University Hospital and were blinded to the study arm of each
patient.
Neurologic end points for the composite outcome included
stroke, TIA, coma, delirium, and memory deficit. Strokes were
defined as a new focal neurologic deficit, confirmed by cranial
computed tomography (CT) scan showing a new ischemic lesion.
CT scans were ordered for patients with neurologic problems
equivalent to an National Institutes of Health stroke score change
of 4 or greater from baseline that did not resolve within 24 hours.
Changes were defined as TIA if they substantially resolved in 24
hours and presented a negative CT scan. Coma applied to patients
not regaining consciousness in the 24 hours after termination of
sedation. Delirious patients exhibited confusion or an altered state
of consciousness during hospitalization. Coma and delirium were
also assessed clinically. The determination of memory loss used 5
questions regarding the patient’s operation and hospital stay.
Memory deficit in nondelirious patients was defined as clinical
retrograde amnesia and assessed through postoperative question-
ing. Patients giving erroneous answers to 2 or more memory
assessment questions were judged as memory deficient. Patients
assessed with memory deficit or delirium at any time were cate-
gorized as memory deficit or delirium end points even if symptoms
resolved by discharge.
Statistical Methodology
A statistical analysis investigated the effects of filter use on a
composite neurologic outcome consisting of stroke, TIA, coma,
delirium, or memory deficit. Each patient with at least 1 of these
components was included as an adverse outcome. Because filters
were not assigned in a prospective randomization scheme, a pro-
pensity score approach was taken to account for possible differ-
ences between treatment groups.11 Of the 582 patients enrolled in
this study, 46 experienced a qualifying composite event.
In all tables of univariable results, P values associated with
continuous variables were generated by Wilcoxon 2-sample tests
because the factors were not normally distributed. For the cate-
goric variables, patient demographics between groups were com-
pared using 2 tests or, if small expected cell frequencies, exact
tests. Continuous variables are presented as means  standard
deviations, and categoric variables are presented as percentages.
Logistic regression modeling was used for both the propensity
model and the model for composite outcome. Linearity assump-
tions for logistic models were checked, and appropriate data trans-
formations were made. Lists of variables considered in the models
are given in Appendix 1. The strategy for both models was to
include only those factors that are known before procedure, in-
cluding the type of procedure. Any variables with low frequency of
occurrence were not used. Mean value imputation was used in the
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case of missing values for “missingness” of up to approximately
10%.
The strategy for obtaining a propensity model was to first
develop a parsimonious model to describe patients who received
filters. Stepwise selection techniques were used with a P value of
.15 for entry. A P value of .10 was considered statistically signif-
icant. Model selection was validated using bootstrap techniques.12
After the model was finalized, additional nonsignificant factors
were included to adjust for other possible differences. Selected
demographic, preoperative, and procedural variables for the
matched population are shown in Appendix 2. This final nonpar-
simonious model produced a propensity score for each patient that
predicts the probability of being a patient who received a filter.
To assess the quality of this score, patients were ranked by
increasing propensity for filter and grouped accordingly into 5
subgroups or quintiles. If the propensity score has been constructed
well, there should not be significant differences in baseline char-
acteristics between patients in the filter and non-filter groups. In
addition, the propensity score was used to match patients from the
filter and non-filter groups.13 In this way, a subset of the total
population was obtained that behaved like a randomized group.
The final model was verified on this subset.
Logistic modeling of the outcome variable included the filter
group variable and then used stepwise selection techniques to
determine other significant adjustments. A P value of .15 was used
for entry and .10 was considered statistically significant. Model
selection was validated using bootstrap techniques. After all base-
line and procedural adjustments were made, the propensity score
was added to the model.
Results
Demographic, preoperative, and procedural descriptors of
the filter group are given in Tables 1 and 2. The logistic
model for the filter group, used to construct a propensity
score, is given in Table 3. The model presented has a
reasonable fit but not good predictive ability (C statistic 
0.64). Patients who had a history of carotid stenosis or low
cardiac output were more likely to get a filter. Patients with
aortic disease, hypercholesterolemia, or history of conges-
tive heart failure were less likely to receive a filter. Female
patients were also less likely to receive a filter.
Quintiles for the filter group showed good matching
across characteristics within each quintile as determined by
Pvalues of greater than .05, which indicate a lack of signif-
icant differences for the characteristics. One-to-one match-
ing was performed between the groups using the propensity
score. A total subpopulation of 474 patients was obtained;
39 of the 46 outcomes were retained in the subpopulation.
Appendix 2 characterizes this group on the basis of the
distinguishing characteristics for the filter group. The
matching process has balanced the differences well.
Selected demographic, clinical history, and procedural
descriptors for composite outcomes are shown in Table 4. A
summary of individual composite measures is shown in
Table 5. There was a significant difference between the filter
and no-filter groups for TIA (P  .051), delirium (P 
.044), and memory deficit (P  .002). The number of
strokes was decreased in the filter group compared with the
no-filter group (0.7% vs 2.2%), although the difference was
not significant. Comparing the composite outcomes be-
tween the filter (13/304, 4.3%) and no-filter (33/278, 11.9%)
groups showed significantly (P  .001) less neurologic
outcomes in the patients with filters.
Table 6 presents the logistic model results for the entire
population with the propensity score included (C statistic 
0.75). The use of a filter during cardiac surgery is associated
with an adjusted odds ratio of 0.375. This implies that a
patient who does not receive a filter is approximately 2.7
times as likely to experience an outcome after adjusting for
other significant factors.
Increasing age is also predictive of poor outcome (Figure
1). Note that the variable in the model is log transformed.
This implies the impact of increasing age with respect to
outcome is not as great for younger patients. The effect is
stronger for older patients. The benefit of the filter seems to
increase with increasing age, although the interaction of age
and filter use on composite outcome did not reach signifi-
cance. A history of liver dysfunction (odds ratio  3.111)
and peripheral vascular disease (odds ratio  2.288) in-
creases the chances for a neurologic outcome. A history of
myocardial infarction occurring greater than 7 days preop-
eratively (odds ratio  0.493) is protective of outcome.
The propensity score is not significant in the model, nor
did it alter the magnitude or direction of any of the findings.
The model applied to the matched subset population agrees
well with the results for the entire population (data not
shown). All findings were in agreement with the exception
of peripheral vascular disease (no longer significant). The
results of these propensity score methods confirm the ben-
efit of filter use after accounting for the lack of randomized
treatment groups.
Particulate debris was extracted from 98% of patients
receiving intra-aortic filtration. Greater than 72% of the
filters contained fibrous atheroma, including grumous and
fibrocalcific atheroma. Platelets and fibrin were found in
69% of filters, thrombus clot was found in 8%, and medial
tissue was found in 1.3%.
Discussion
A flurry of activity and innovation in the field of cardiac
surgery have been seen in the last 10 years. In the ongoing
quest to reduce complications and trauma, progress has been
made in minimally invasive tools and techniques. Beating
heart surgery has received unprecedented attention, which
has resulted in the development of sophisticated retractors,
stabilizers, and heart positioners. Robotic surgery has rap-
idly evolved. Many have theorized that these advances
should improve neurologic outcomes.
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Despite this intense effort, neurologic injury remains a
devastating and tenacious surgical complication. Patients,
families, surgeons, and the entire health care system bear a
great burden each time a cardiac surgery ends in an adverse
cerebral outcome. Roach and colleagues’5 landmark article
looked at 2108 patients across 24 centers and demonstrated
that 6.1% of patients undergoing CABG experience an
adverse cerebral outcome, a far more common phenomenon
than previously recognized. They further reported that these
patients demonstrated 5 to 10 times the mortality and 2 to 4
times the length of stay in intensive care, and required 3 to
6 times the prolonged care when compared with patients
without adverse cerebral events. Although a multifactorial
cause of this problem is recognized, aortic atheromatosis
has repeatedly been reported as the greatest risk factor, and
recent articles have highlighted the central role of particu-
late emboli in neurologic injury.1,2,5
Early studies using transesophageal echocardiography
and transcranial Doppler demonstrated the embolic activity
associated with surgical manipulation of the heart and the
aorta during surgery.3 In patients receiving intra-aortic fil-
tration, the filter is deployed during the surgical period most
TABLE 1. Patient demographics and clinical history by filter group
Parameter No filter Filter P value
Total number of patients N 278 304
Patient age N 277 304 .072
Mean  SD 66.7 9.00 65.4 9.31
Median 68.0 66.0
Male gender n/N (%) 198/276 (71.7) 239/304 (78.6) .055
Endocarditis n/N (%) 3/273 (1.1) 3/302 (1.0) 1.000
Carotid stenosis  50% n/N (%) 15/264 (5.7) 36/295 (12.2) .008
Congestive heart failure n/N (%) 15/274 (5.5) 9/301 (3.0) .137
Preop LVEF N 276 300 .155
Mean  SD 59.6  13.74 58.1  14.49
Median 63.0 60.0
NYHA class N 274 301 .107
1 n (%) 26 (9.5) 15 (5.0)
2 n (%) 94 (34.3) 98 (32.6)
3 n (%) 110 (40.1) 143 (47.5)
4 n (%) 44 (16.1) 45 (15.0)
Unstable angina n/N (%) 43/276 (15.6) 49/299 (16.4) .792
Aortic disease n/N (%) 57/274 (20.8) 40/303 (13.2) .015
Acute MI n/N (%) 90/276 (32.6) 100/302 (33.1) .898
MI (7 d) n/N (%) 109/275 (39.6) 135/299 (45.2) .182
Left main disease n/N (%) 62/274 (22.6) 81/299 (27.1) .218
Atrial arrhythmia n/N (%) 46/271 (17.0) 56/296 (18.9) .547
Ventricular arrhythmia n/N (%) 25/269 (9.3) 32/298 (10.7) .568
Low cardiac output n/N (%) 12/274 (4.4) 24/302 (7.9) .077
Aortic plaque grade N 230 269 .397
I n (%) 139 (60.4) 163 (60.6)
II n (%) 65 (28.3) 66 (24.5)
III n (%) 26 (11.3) 40 (14.9)
Transient ischemic attack n/N (%) 32/276 (11.6) 38/299 (12.7) .683
Stroke n/N (%) 16/274 (5.8) 20/304 (6.6) .713
Neurologic deficit n/N (%) 7/276 (2.5) 6/300 (2.0) .665
Diabetes (insulin-dependent) n/N (%) 37/276 (13.4) 33/304 (10.9) .346
Diabetes (oral medications) n/N (%) 38/277 (13.7) 35/304 (11.5) .423
Smoker n/N (%) 58/213 (27.2) 72/205 (35.1) .081
Alcohol use 3 n/N (%) 10/254 (3.9) 7/282 (2.5) .337
Renal dysfunction n/N (%) 31/275 (11.3) 43/303 (14.2) .294
GI bleed n/N (%) 20/268 (7.5) 23/298 (7.7) .909
Obesity n/N (%) 160/275 (58.2) 159/303 (52.5) .168
Liver dysfunction n/N (%) 30/264 (11.4) 27/292 (9.2) .411
Peripheral vascular disease n/N (%) 58/273 (21.2) 53/296 (17.9) .315
Pulmonary dysfunction n/N (%) 60/277 (21.7) 58/301 (19.3) .476
Hypertension n/N (%) 222/276 (80.4) 235/303 (77.6) .397
Hypercholesterolemia n/N (%) 222/276 (80.4) 220/303 (72.6) .027
LVEF, Left ventricular ejection fraction; MI, myocardial infarction; GI, gastrointestinal; NYHA, New York Heart Association. P values: Wilcoxon 2-sample test,
2 test, and Fisher exact test.
Cardiopulmonary Support and Physiology Schmitz et al
1832 The Journal of Thoracic and Cardiovascular Surgery ● December 2003
CSP
associated with embolization, including partial clamping,
sewing anastomoses, and removal of the aortic crossclamp.
Intra-aortic filtration has emerged as the only technology to
date capable of capturing and removing particulate emboli
from the circulation. Previous reports by the ICEM Study
Group focused analysis on a multicenter registry designed
to gain statistical relevance by pooling data. These studies
have been instrumental in demonstrating that intra-aortic
filtration can be performed safely, that it successfully cap-
tures and removes particulate debris from the aorta, and that
postoperative complications are reduced when compared
with risk indices and historical controls.
Prior studies by the ICEM benefited from the ability to
draw from 17 participating centers, allowing the aggregate
patient group to reach more than 1600 patients in a consec-
utive enrollment registry. A study of this size has the
advantage of providing meaningful background statistics,
because category sizes remain large even when subgroups
are examined. Because of this, important subset studies such
as that reported by Schmitz and Blackstone8 on behalf of the
ICEM Study Group could look at a subset of patients
undergoing only CABG in enough detail to assess their
outcomes with a published, validated stroke risk index.
They reported approximately 50% fewer neurologic out-
comes in patients receiving intra-aortic filtration when com-
pared with expected events (1.5% vs 3.4%, P  .03).
Similarly, there were enough patients for Wimmer-Gre-
inecker9 to examine a high-risk group of patients receiving
concomitant CABG and intracardiac surgery. In his presen-
tation at the 2001 European Association for Cardiothoracic
Surgery meeting in Lisbon, Wimmer-Greinecker reported
74% fewer type I neurologic outcomes in this group when
compared with a previous study.
This is the first study comparing a control group with a
filter group in a single center. Although the study loses the
power of the aggregate numbers, it gains the advantage of
greater homogeneity through greater control over the pro-
cedural variables and patient population. All patients under-
went operations by the same surgeons, at the same center,
with the same tools and techniques. The procedure mix was
very similar. The same outcome definitions and assessments
were applied to all patients across both arms. The effect of
the intra-aortic filter is thus more isolated than in previous
investigations.
Exclusion criteria were applied in a further effort to
ensure homogeneity across study arms. Patients with carotid
stenosis greater than 70% were excluded because of the
possibility of carotid effects on neurologic outcome con-
TABLE 2. Procedure category by filter group
Parameter No filter Filter P value
Total number of patients N 278 304
Emergency surgery n/N (%) 6/275 (2.2) 6/302 (2.0) .870
Valve procedure n/N (%) 20/278 (7.2) 11/304 (3.6) .055
CABG n/N (%) 226/278 (81.3) 258/304 (84.9) .250
CABG/valve combination n/N (%) 28/278 (10.1) 29/304 (9.5) .829
Other procedure n/N (%) 4/278 (1.4) 6/304 (2.0) .754
Previous CABG or valve n/N (%) 7/275 (2.5) 4/299 (1.3) .292
CABG, Coronary artery bypass graft. P values: 2 and Fisher exact test.
TABLE 3. Adjusted logistic regression results (propensity model) for the filter group
Outcome Coefficient SE Odds ratio Odds ratio CI P value
Filter (N  582, No. filters  304)
Demographics:
Patient age 0.013 0.010 0.988 (0.969, 1.006) .195
Female gender 0.263 0.208 0.769 (0.511, 1.155) .206
Clinical history:
Carotid stenosis  50% 0.960 0.331 2.611 (1.366, 4.992) .004
Low cardiac output 1.034 0.435 2.812 (1.199, 6.595) .017
Aortic disease 0.633 0.264 0.531 (0.316, 0.891) .017
Congestive heart failure 1.011 0.517 0.364 (0.132, 1.002) .050
Hypercholesterolemia 0.553 0.208 0.575 (0.383, 0.865) .008
Procedure:
Valve procedure 0.393 0.416 0.675 (0.298, 1.526) .345
CABG/valve combination 0.097 0.339 1.102 (0.567, 2.142) .774
CI, Confidence interval. Wald 2 statistics and P values; C statistic  0.64; Hosmer-Lemeshow goodness of fit: 2  4.90, df  8, P value  .77.
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founding the effects of the surgery. In addition, patients
with less than 20% left ventricular ejection fraction were
also excluded. These patients were excluded to ensure that
all patients could be assessed with the complete range of
neuropsychologic tests that were part of the full protocol.
Of the 46 composite neurologic outcomes, the filter
group had 28.3% (13/46) and the control group had 71.7%
(33/46). As expected, individual subcategories of neuro-
logic injury had less statistical power, although TIA (P 
.05), delirium (P  .04), and memory deficit (P  .002)
each achieved significance independently. The stroke sub-
category trended toward reduced occurrence in the filter
group. In parallel with the overall reduction of individual
outcomes, fewer patients experienced a composite adverse
neurologic outcome in the filter group (13/304, 4.3%) when
compared with the control group (33/278, 11.9%) (P 
.001). That some preoperative variables provided a protec-
tive benefit or were predictive of an outcome may be caused
in part by the low incidence of outcomes in this population
or other possible coexisting conditions.
Preoperative variables between the 2 groups showed
some differences, but these were adjusted for in the logistic
model. Variables with significant influence and sufficient
frequency were included in the propensity score model.
TABLE 4. Selected demographics, clinical history, and procedure category by composite outcome
Parameter Statistic No outcome Yes outcome P value
Total number of patients N 536 46
Demographics:
Patient age N 535 46 .016
Mean  SD 65.7  9.27 69.3  7.32
Median 67.0 70.5
Male gender n/N (%) 405/534 (75.8) 32/46 (69.6) .343
Clinical history:
Congestive heart failure n/N (%) 21/529 (4.0) 3/46 (6.5) .429
Carotid stenosis 50% n/N (%) 45/515 (8.7) 6/44 (13.6) .274
Calcification ascending aorta n/N (%) 188/522 (36.0) 19/46 (41.3) .475
Aortic disease n/N (%) 85/531 (16.0) 12/46 (26.1) .079
MI (7 d) n/N (%) 178/532 (33.5) 12/46 (26.2) .019
Atrial arrhythmia n/N (%) 88/522 (16.9) 14/45 (31.1) .017
Transient ischemic attack n/N (%) 60/529 (11.3) 10/46 (21.7) .039
Smoker n/N (%) 118/383 (30.8) 12/35 (34.3) .671
Renal dysfunction n/N (%) 66/532 (12.4) 8/46 (17.4) .332
Liver dysfunction n/N (%) 47/513 (9.2) 10/43 (23.3) .008
Peripheral vascular disease n/N (%) 96/523 (18.4) 15/46 (32.6) .019
Pulmonary dysfunction n/N (%) 103/532 (19.4) 15/46 (32.6) .032
Hypertension n/N (%) 419/533 (78.6) 38/46 (82.6) .524
Procedure:
Emergency surgery n/N (%) 10/531 (1.9) 2/46 (4.3) .247
Valve procedure n/N (%) 29/536 (5.4) 2/46 (4.3) 1.000
CABG n/N (%) 449/536 (83.8) 35/46 (76.1) .182
CABG/valve combination n/N (%) 48/536 (9.0) 9/46 (19.6) .034
Previous CABG or valve n/N (%) 9/530 (1.7) 2/44 (4.5) .203
Treatment:
Filter n/N (%) 291/536 13/46 .001
P values: Wilcoxon 2-sample test, 2, and Fisher exact test.
TABLE 5. Summary of composite neurologic outcomes
Parameter No filter Filter P value
Total number of patients N 278 304
Stroke n/N (%) 6/278 (2.2) 2/304 (0.7) .161
Transient ischemic attack n/N (%) 4/278 (1.4) 0/304 (0.0) .051
Delirium n/N (%) 18/278 (6.5) 9/304 (3.0) .044
Coma n/N (%) 1/277 (0.4) 1/304 (0.3) 1.000
Memory deficit n/N (%) 17/276 (6.2) 4/304 (1.3) .002
All composite outcomes n/N (%) 33/278 (11.9) 13/304 (4.3) .001
P values: 2 and Fisher exact test.
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That some patients were more likely to receive a filter or not
with the presence of certain preoperative variables was
probably because a formal randomization scheme was not
applied during patient selection. The propensity score was
included in the model of outcome as an adjustment to
compensate for bias. Although the propensity matching is a
multivariate method that is the observational analog of
randomization and controls for observed variables, it does
not control for unobserved variables. Nonetheless, this
model considered 37 variables and used all significant vari-
ables (n  9) that provided good matching (P  .05 for
variables) using a large percentage of the population. The
model results remained consistent within the matched sub-
set.
Important findings in this study include the benefit of
filter use and the detriment of increasing age. Many studies
have identified older patient age as a significant risk for
adverse neurologic outcomes. The reason for this may in
part be caused by increased preoperative risk conditions.
The current results indicate that an 80-year-old patient with
the filter might expect the equivalent outcome of a 55-year-
old without the filter. Although the interaction of age and
filter on outcomes was not significant, probably because of
the low incidence of outcomes, there is a trend in this
direction that warrants further investigation. It seems the
older population may greatly benefit from intra-aortic fil-
tration.
The mechanism for these results is most likely the ex-
traction of particulate emboli from the aorta before they can
travel distally and occlude important blood vessels. The
chain of events—aortic atheroma, surgical manipulation,
embolization, distal travel, and arterial occlusion—is appar-
ently impeded when the emboli are captured and removed,
making arterial occlusion less likely.
Two approaches have now been used to examine intra-
aortic filtration. Previous ICEM studies have demonstrated
the breadth of applicability of the filter in extracting partic-
ulate emboli safely in many patients. In addition, these
studies have strongly suggested a clinical benefit. In our
single-center controlled study, the evidence for a clinical
benefit from filtration has become even more compelling.
An even stronger study would combine breadth with control
in a multicenter, randomized, controlled study.
Limitations
Further study could improve on the present investigation in
several ways. A larger sample size could help to determine
the effect of intra-aortic filtration on individual neurologic
outcome categories. Our finding was notably most signifi-
cant with the composite of neurologic outcomes. Although
we believe that intra-aortic filtration has a significant effect
on focal neurologic events such as stroke and coma, enroll-
ment in the present study is not high enough to show more
than a trend in these areas. Furthermore, some of the indi-
vidual outcomes are likely to be correlated. To address this
possibility, we have only included patient outcome results
in which each patient is counted only as demonstrating 1 of
the 5 neurologic measures or not. The outcome of composite
neurologic finding represented less than 10% of the popu-
lation of 582 patients.
A model built on 46 events must be interpreted with
caution and emphasizes the problem of evaluating outcomes
when the incidence is very low. Most of the information
available for analysis was clinical history (binary variables).
This does not allow for the best predictive model construc-
tion. However, in the propensity-matching analysis, 81% of
the total patients and 85% of the outcomes were included.
This resulted in a well-matched evaluation between the filter
and non-filter groups.
Patients in this study were not assigned per a random-
ization scheme. Although our analysis of preoperative risk
factors, demographics, and procedure category using pro-
pensity score matching account for many of the differences
between groups, an even stronger case could be made in a
study with a formal randomization scheme.
TABLE 6. Logistic regression model results with propensity score included for composite neurologic outcome
Outcome Coefficient SE Odds ratio Odds ratio CI P value
Composite outcome
(N  582, no. events  46)
Demographics
Patient age (log transformed) 2.762 1.387 15.83 (1.044, 240.0) .047
Clinical history
Liver dysfunction 1.135 0.410 3.111 (1.393, 6.949) .006
Peripheral vascular disease 0.828 0.354 2.288 (1.143, 4.578) .019
MI (7 d) 0.706 0.362 0.493 (0.243, 1.002) .051
Procedure:
Filter used 0.980 0.355 0.375 (0.187, 0.752) .006
Probability of filter (propensity score adjustment) 0.260 1.349 0.771 (0.055, 10.85) .847
Wald 2 statistics and P values; C statistic  0.75; Hosmer-Lemeshow goodness of fit: 2  7.29, df  8, P value  .50.
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This study only looks at outcomes occurring during
hospitalization. More study is needed to look at long-term
effects of filtration on neurologic outcomes.
In this investigation, outcomes were assessed on a di-
chotomous scale; a patient was in an outcome category or
not. Using graduated assessments of neurologic condition
would enable more nuanced and powerful analysis.
Finally, this study looked at damage to only 1 distal
organ: the brain. However, many other distal organs may be
damaged by particulate emboli. In their autopsy study,
Blauth and colleagues14 reported emboli in the kidneys,
gastrointestinal tract, and lower extremities. Further studies
should examine intra-aortic filtration’s effect on these or-
gans. Studies are currently in progress to evaluate more
subtle neurologic effects as may be detected by neuropsy-
chologic testing.
Conclusions
This study demonstrates that in our center, the general
cardiac surgery patient population benefited from signifi-
cantly decreased neurologic outcomes through the use of
intra-aortic filtration after all significant adjustments and
after accounting for the lack of randomization. A patient
without a filter during a procedure might expect a 2.7 times
greater chance of experiencing an adverse outcome. Older
patients seem to particularly benefit from the filter. In con-
junction with earlier studies of particulate extraction, it is
becoming increasingly clear that intra-aortic filtration is
indicated in cases involving aortic manipulation and central
anastomoses.
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Discussion
Dr H. Vanermen (Aalst, Belgium). In view of the fact that this
was a nonrandomized study, could you give us some more detail
on how patients were chosen to go into 1 arm of the study or
another, and could this potentially bias the results?
Dr Schmitz. Originally we had a strict randomization scheme,
but it turned out that we were not able to enroll large numbers of
patients. That is why we changed our enrollment scheme in that
way. All patients were enrolled preoperatively, but the treatment
assignment was based on alternate time periods, and we tried to
balance the numbers in both groups.
Dr Vanermen. In conjunction with earlier studies on intra-
aortic filtration, what do you believe is the current understanding
of the indications for use of the device?
Dr Schmitz. We had a lot of discussion about this question in
our ICEM group. Most centers try to find high-risk patients for
Figure 1. Model results for composite neurologic outcome for the
entire population predict the probability of an outcome for pa-
tients with increasing age and no history of liver disease, myo-
cardial infarction, or peripheral vascular disease. Predicted prob-
abilities (solid lines); 1 SD (dashed gray lines) (70% confidence
limits).
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